Our Approach

VVC identifies, invests in and supports best-in-class companies that are positioned to leverage innovative product development leading to rapid high value market entry and commercialization.

Specifically, we target companies in the food and companion animal health markets that develop pharmaceuticals, vaccines, diagnostics, science-based wellness products, and, drug delivery mechanisms.

VVC invests between $100,0000 and $5 million at inception and may increase each investment on a staged basis to double that amount over time.

Our broad relationships enable VVC to share an extensive global network with our portfolio companies, and our deep sector expertise allow us to accelerate growth in ways that most other investors are not able.